2m 2m 2m 2m 2m 2m 2m
Standard BioTool (LAB)
NASDAQ
$0.65-$0.02 (-2.26%)
Price as of Nov 11, 2026 7:30 PM EST- $262.5MMarket Cap
- -44.12%1-Year Change
- Medical DevicesIndustry
Standard BioTool (LAB)
$0.65-$0.02 (-2.26%)
LAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.67 | ||
Change | -$0.03 (-4.21%) | ||
Open | $0.69 | ||
High | $0.69 | ||
Low | $0.66 | ||
Previous Close | $0.69 | ||
Volume | 327,235 | ||
30-Day Average Volume | 799,389 | ||
1-Week Change | 8.87% | ||
1-Month Change | -3.54% | ||
1-Year Change | -44.12% | ||
3-Year Change | -69.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 394.8M | ||
Total Assets | $635.3M | ||
Market Cap | $262.5M | ||
Enterprise Value | -$4.7M | ||
Period: QTR TTM FY | |||
Revenue | $14.3M | ||
Net Income | $13.5M | ||
Free Cash Flow | -$6.2M | ||
EBIT | $13.5M | ||
EBITDA | $13.5M | ||
Net Working Capital | $446.3M | ||
EPS | $0.03 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | -0 | ||
P/B | 0 | ||
P/E | 22 | ||
PEG | 0 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue